CoChat

Selenium supplementation decreases nuclear factor‐kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients

Faure, P., Ramon, O., Favier, A., Halimi, S. · 2004 · European Journal of Clinical Investigation
Cited by 81

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objective The role of selenium in preventing cardiovascular diseases has been largely described. Oxidative stress and the subsequent activation of nuclear factor‐kappa B (NF‐κB) have been linked to the development of vascular complications. We investigated the effects of selenium supplementation in type 2 diabetic patients on several oxidative stress parameters and NF‐κB activity. Methods We enrolled 56 type 2 diabetic patients with similar glycaemic control: 21 were supplemented by selenium (960 µg d−1, 3 months) and 27 received a placebo, and 10 nondiabetic subjects formed the control group. To determine NF‐κB activation, we used an electrophoretic mobility shift assay followed by a semi‐quantitative determination of NF‐κB in peripheral blood mononuclear cells. Results Selenium treatment resulted in a significant increase in plasma selenium and red‐cell Se GSH px activity. It had no effect on lipid peroxidation measured by malone‐dialdehyde (MDA) or on red‐cell Cu/Zn SOD. NF‐κB activity was increased by 80% in diabetic patients. In patients receiving selenium supplementation, selenium NF‐κB activity was significantly reduced, reaching the same level as the nondiabetic control group. Conclusion In type 2 diabetic patients, activation of NF‐κB measured in peripheral blood monocytes can be reduced by selenium supplementation, confirming its importance in the prevention of cardiovascular diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2004.01362.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 81

Metadata

Authors
Faure, P., Ramon, O., Favier, A., & Halimi, S.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2004-07
Volume
34
Issue
7
Pages
475-481
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2050962873
Cited by
81
References
3
FWCI
3.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selenium supplementation decreases nuclear factor‐kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. https://app.cochat.ai/papers/10.1111/j.1365-2362.2004.01362.x
The paper
Faure, P., Ramon, O., Favier, A., & Halimi, S. (2004). Selenium supplementation decreases nuclear factor‐kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2004.01362.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.